- Q2 earnings underway, FDA’s CRL kerfuffle, IPOs full speed ahead in H2Second quarter earnings continue to roll with Novartis and Roche reporting this week; Eli Lilly’s AtaiBeckley buy for up to $3.8 billion offers clear “validation” for the fledgling psychedelics spa…BioSpace · 2d ago↗ source
- House passes bill directing FDA to update animal testing rulesThe U.S. House of Representatives passed the FDA Modernization Act 3.0 this week, and lawmakers and animal welfare advocates are celebrating the bill as a step toward a new era in preclinical testi…Fierce Biotech · 2d ago↗ source
- STAT+: ‘Cochlear implant for blindness’ debuts in Europe, could launch in U.S. in 2027Science Corporation announced the European launch of its retinal implant for patients with age-related macular degeneration.